Related references
Note: Only part of the references are listed.The role of PNPLA3 in health and disease
Piero Pingitore et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2019)
A simple approach for restoration of differentiation and function in cryopreserved human hepatocytes
Magnus Olander et al.
ARCHIVES OF TOXICOLOGY (2019)
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
P. Dongiovanni et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Ensembl 2018
Daniel R. Zerbino et al.
NUCLEIC ACIDS RESEARCH (2018)
Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery
Lorna Ewart et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2018)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes et al.
JOURNAL OF HEPATOLOGY (2018)
Human hepatic 3D spheroids as a model for steatosis and insulin resistance
Mikael Kozyra et al.
SCIENTIFIC REPORTS (2018)
Protein Phosphatase 1 Regulatory Subunit 3B Gene Variation Protects Against Hepatic Fat Accumulation and Fibrosis in Individuals at High Risk of Nonalcoholic Fatty Liver Disease
Paola Dongiovanni et al.
HEPATOLOGY COMMUNICATIONS (2018)
Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances
Jennie Ka Ching Lau et al.
JOURNAL OF PATHOLOGY (2017)
TM6SF2 rs58542926 Impacts Lipid Processing in Liver and Small Intestine
Elizabeth A. O'Hare et al.
HEPATOLOGY (2017)
Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis
Nicole Ehrhardt et al.
HUMAN MOLECULAR GENETICS (2017)
Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD
Panu K. Luukkonen et al.
JOURNAL OF HEPATOLOGY (2017)
Novel association of TM6SF2 rs58542926 genotype with increased serum tyrosine levels and decreased apoB-100 particles in Finns
Daniel Seung Kim et al.
JOURNAL OF LIPID RESEARCH (2017)
Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci
Stefan Stender et al.
NATURE GENETICS (2017)
The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis
Zhengtao Liu et al.
SCIENTIFIC REPORTS (2017)
Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice
Yanbo Fan et al.
GASTROENTEROLOGY (2016)
Diverse Impacts of the rs58542926 E167K Variant in TM6SF2 on Viral and Metabolic Liver Disease Phenotypes
Mohammed Eslam et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins
Eriks Smagris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
Sven M. Francque et al.
JOURNAL OF HEPATOLOGY (2016)
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2016)
The Role of Cholesterol in the Pathogenesis of NASH
George N. Ioannou
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease
Catherine C. Bell et al.
SCIENTIFIC REPORTS (2016)
Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
Graciela Arguello et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
The application of engineered liver tissues for novel drug discovery
Christine Lin et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease
Paola Dongiovanni et al.
HEPATOLOGY (2015)
Animal models of human disease: Challenges in enabling translation
Paul McGonigle et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk
Oddgeir L. Holmen et al.
NATURE GENETICS (2014)
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
Julia Kozlitina et al.
NATURE GENETICS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Multi-cell type human liver microtissues for hepatotoxicity testing
S. Messner et al.
ARCHIVES OF TOXICOLOGY (2013)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Yuki Kawano et al.
JOURNAL OF GASTROENTEROLOGY (2013)
The global NAFLD epidemic
Rohit Loomba et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
Animal models of nonalcoholic fatty liver disease
Lionel Hebbard et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Share Paper
